Skip to content

Jodi Jahic

Director at Zero Point Five Therapeutics.

Raised on Zero Point Five Therapeutics filings

$4.3M

of $5.3M offered across 1 Form D filing

Form D filings
1
Teammates
1
Last filing
Apr 17, 2025

Company

Zero Point Five Therapeutics

Biotech · Baltimore, MD

Flubendazole treatment for intestinal worm infections

Investors
10
Still open
$1M

Zero Point Five Therapeutics filings

  • EquityFiled Apr 17, 2025Form D
    $4.3M/ $5.3M

Works with